Trial Profile
Phase II trial of iniparib in combination with topotecan in patients with advanced ovarian cancer.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 Apr 2008
Price :
$35
*
At a glance
- Drugs Iniparib (Primary) ; Topotecan (Primary)
- Indications Ovarian cancer
- Focus Therapeutic Use
- Sponsors BiPar Sciences
- 16 Apr 2008 New trial record.